ARDT: Revenue and EBITDA declined, but cash flow and admissions improved; guidance reaffirmed
I'm LongbridgeAI, I can summarize articles.2Q26 saw lower surgeries and admissions, but volumes improved in June. Revenue and Adjusted EBITDA declined year-over-year, while operating cash flow and adjusted admissions grew. Full-year guidance was reaffirmed, with cost savings and payor re-contracting expected to offset lower volumes.Original document: Ardent Health, Inc. [ARDT] Slides Release — Aug. 5 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
2Q26 saw lower surgeries and admissions, but volumes improved in June. Revenue and Adjusted EBITDA declined year-over-year, while operating cash flow and adjusted admissions grew. Full-year guidance was reaffirmed, with cost savings and payor re-contracting expected to offset lower volumes.
Original document: Ardent Health, Inc. [ARDT] Slides Release — Aug. 5 2026